STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentrationJing Chen, Mubiao Liu, Shuting Huang et al.|Clinical & Translational Oncology|2022Cited by 10
Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic CancersHao Wen, Xiaohua Wu, Qin Xu et al.|JAMA Network Open|2023Cited by 10
Abstract 5872: Investigation on the prevalence of germline and somatic mutations in gynecological malignancies: Implications for risk assessment and therapeutic decision-makingHao Wen, Xiaohua Wu, Qin Xu et al.|Cancer Research|2022Cited by 0